Talcum Powder Cancer Lawsuit

Johnson & Johnson's $4.7 Billion Appeal Faces New Hurdles

There have been significant developments that could affect the outcome of the appeal of one of the largest jury awards in history

Monday, May 4, 2020 - One of the more financially impactful decisions that Johnson & Johnson faces in the coming days is whether or not a Missouri appeals court will grant the company's request to reverse a $4.7 billion verdict and jury award rendered against them last year. In a 2018 talcum powder cancer lawsuit, 22 women claimed that they developed and were suffering from ovarian cancer as a result of a lifetime of using Johnson's Baby powder on the peritoneal region of their bodies for the purpose of feminine hygiene. Attorneys for Johnson & Johnson argued that the verdict should be overturned on administrative grounds because each plaintiff has different stages of cancer and each hail from different backgrounds where they each may have been exposed to other carcinogenic contaminates at home or at work, a strikingly strong argument. In addition, Johnson & Johnson recently won a similar trial when the plaintiff could not prove that her ovarian cancer was not potentially due to having endometriosis. In December of 2018, Johnson & Johnson lost its first motion to appeal the record-setting jury award prompting the company's leader to tell reporters at CNBC that he remained confident that the appeals court would overturn the jury's decision and that studies proved his talc was pure and "asbestos-free". The Times reports, "Alex Gorsky, the chief executive of Johnson & Johnson, told CNBC on Monday that, based on "thousands of studies," the company "unequivocally" believes that its talc does not contain asbestos."

Since then the purity of Johnson & Johnson's talc has come under fire because the testing methods the company used for decades may be insufficient to find asbestos fibers and also because the company just didn't look very hard. CEO Gorsky's statement of "unequivocally believing that talc does not contain asbestos," was contradicted by independent tests conducted by the US Food and Drug Administration, found asbestos fibers and other harmful contaminants known to be a carcinogen and possibly responsible for causing cancer such as mesothelioma, in unopened bottles of Johnson's Baby Powder.

All this was happening parallel to Daubert hearings in New Jersey that started in July of 2019 and recently concluded over the validity of expert witnesses that were offering similar scientific testimony over and over in every talcum powder cancer trial. In order to put an end to the skepticism over the credibility of certain expert testimony, Federal Judge Freda Wolfson decided in a New Jersey court that over 12,000 talcum powder/ovarian cancer sufferer's lawsuits may proceed to trial. In the decision, Judge Wolfson concluded that expert testimony where scientific tests proved not only that Johnson' Baby Powder contains asbestos, but also that such powder can enter the ovaries through the vagina when applied regularly and over a period of many years for hygienic purposes, may be presented to juries. In addition, the US FDA is in the process of insisting that the entire cosmetics industry use more sensitive asbestos testing methods such as the liquid separation method to enhance their ability to find asbestos in talc and screen out the product that may be contaminated.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.